The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.1 and HLA-DR1

European Journal of Immunology

Volumn 37, Issue 9, 2007, Pages 2635-2644

  Pajot, Anthony ^a   Schnuriger, Auréllie ^b   Moris, Arnauld ^a   Rodallec, Audrey ^c   Ojcius, David M ^d   Autran, Brigitte ^b   Lemonnier, François A ^a   Lone, Y Chun ^a  

^a INSTITUT PASTEUR   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Epitopes; HIV 1; MCH; Vaccines

Indexed keywords

EPITOPE; GAG PROTEIN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PEPTIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; GENETIC CODE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STRUCTURE; SYMPTOM; TH1 CELL; VACCINE PRODUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HIV CORE PROTEIN P24; HLA-A ANTIGENS; HLA-DR1 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; TH1 CELLS;

EID: 34548793580     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636819     Document Type: Article

References (26)

1. Seth, N., Kaufmann, D., Lahey, T., Rosenberg, E. S. and Wucherpfennig, K. W., Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J. Immunol. 2005. 175: 6948-6958.
2. + T cell responses associated with control of viremia. Science 1997. 278: 1447-1450.
3. Rosenberg, E. S., Altfeld, M., Poon, S. H., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K. et al., Immune control of HIV-1 after early treatment of acute infection. Nature 2000. 407: 523-526.
4. Champagne, P., Ogg, G. S., King, A. S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V. et al., Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001. 410: 106-111.
5. + T cells. J. Exp. Med. 2004. 200: 701-712.
6. Hammer, J., Sturniolo, T. and Sinigaglia, F., HLA class II peptide binding specificity and autoimmunity. Adv. Immunol. 1997. 66: 67-100.
7. Castelli, F. A., Buhot, C., Sanson, A., Zarour, H., Pouvelle-Moratille, S., Nonn, C., Gahery-Segard, H. et al., HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J. Immunol. 2002. 169: 6928-6934.
8. Pajot, A., Michel, M. L., Fazilleau, N., Pancre, V., Auriault, C., Qjcius, D. M., Lemonnier, F. A. and Lone, Y. C., A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class 1-/class II-knockout mice. Eur. J. Immunol. 2004. 34: 3060-3069.
9. + T cells: HIV antigen presentation, T cell activation, viral transfer. Blood 2006. 108: 1643-1651.
10. + T cell clones following immune reconstitution on highly active antiretroviral therapy. J. Immunol. 2003. 170: 1106-1116.
11. Wilson, C. C., Palmer, B., Southwood, S., Sidney, J., Higashimoto, Y., Appella, E., Chesnut, R. et al., Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J. Virol. 2001. 75: 4195-4207.
12. + T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 2003. 77: 10900-10909.
13. Kaufmann, D. E., Bailey, P. M., Sidney, J., Wagner, B., Norris, P. J., Johnston, M. N., Cosimi, L. A. et al., Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 2004. 78: 4463-4477.
14. Venturini, S., Mosier, D. E., Burton, D. R. and Poignard, P., Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization. J. Virol. 2002. 76: 6987-6999.
15. Pantaleo, G., Graziosi, C. and Fauci, A. S., Virologic and immunologic events in primary HIV infection. Springer Semin. Immunopathol. 1997 18: 257-266.
16. Firat, H., Tourdot, S., Ureta-Vidal, A., Scardino, A., Suhrbier, A., Buseyne, F., Riviere, Y. et al., Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur. J. Immunol. 2001. 31: 3064-3074.
17. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994. 368: 215-221.
18. Sponaas, A., Carstens, C. and Koch, N., C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells. Gene Ther. 1999. 6: 1826-1834.
19. Rodriguez, F., Harkins, S., Redwine, J. M., de Pereda, J. M. and Whitton, J. L., CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J. Virol. 2001. 75: 10421-10430.
20. Pajot, A., Pancre, V. V., Fazilleau, N., Michel, M. L., Angyalosi, G., Ojcius, D. M., Auriault, C. et al., Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules. Int. Immunol. 2004. 16: 1275-1282.
21. Loirat, D., Lemonnier, F. A. and Michel, M. L., Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 2000. 165: 4748-4755.
22. Freisewinkel, I. M., Schenck, K. and Koch, N., The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 1993. 90: 9703-9706.
23. Candotti, D., Costagliola, D., Joberty, C., Bonduelle, O., Rouzioux, C., Autran, B. and Agut, H., Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. J. Med. Virol. 1999. 58: 256-263.
24. Forsthuber, T., Yip, H. C. and Lehmann, P. V., Induction of Thl and Th2 immunity in neonatal mice. Science 1996. 271: 1728-1730.
25. Samri, A., Durier, C., Urrutia, A., Sanchez, L, Gahery-Segard, H., Imbart, S., Sinet, M. et al., Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay. Clin. Vaccine Immunol. 2006. 13: 684-697
26. Brossart, P., Grunebach, F., Stuhler, G., Reichardt, V. L., Mohle, R., Kanz, L. and Brugger, W., Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood 1998. 92: 4238-4247.